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Immunologist and leader in science. Born in Lisbon, Portugal, on Oct 17, 1939, she died there of COVID-19 on April 14, 2020, aged 80 years.

Although devoted to the study of immunology throughout her career, it was not until the mid-1980s that Maria de Sousa, Emeritus Professor of the University of Porto in Portugal, began to make a wider impact on biomedical science in her home country. In 1984, she returned to Portugal after 20 years abroad, a period during which she had established an international reputation for her work on lymphocytes. After her return, de Sousa set about laying the foundations for improving systematic training programmes for higher level biomedical science. At that time in Portugal, "there was, for example, no arrangement for externally evaluating postgraduate research grants and projects", explains Rui Costa, Professor of Neuroscience and Neurology at New York\'s Columbia University, and Director and Chief Executive Officer of Columbia\'s Zuckerman Institute. de Sousa succeeded in developing a new training system. "In science she became something of a national hero", says Costa.

de Sousa studied medicine at the University of Lisbon, graduating in 1963 but decided almost immediately to opt for science. She moved to the UK in 1964 to work at the then Imperial Cancer Research Fund\'s Experimental Biology Laboratories in north London. Here she met and worked with endocrinologist Delphine Parrott, a pioneer of T cell immunology who had discovered that removal of the mouse thymus caused a profound immunosuppression. Relying solely on microscopy, de Sousa made a close study of thymectomised mice. "She showed that thymectomy produced a depletion in lymphocyte numbers", says immunologist Professor Antonio Freitas, retired head of the Department of Immunology at the Pasteur Institute in Paris. Moreover, adds Henrique Veiga-Fernandes, Principal Investigator in Immunophysiology at the Champalimaud Foundation in Lisbon, "She realised, looking down the microscope, that peripheral lymphoid organs \[of thymectomised mice\] were totally different...Cells which should have been there were not there any more."

After a move to the University of Glasgow, UK, to do a PhD in 1966, de Sousa began investigating lymphocyte activity. "She postulated that the cells produced by the thymus would migrate specifically to the lymphoid organs", explains Freitas. "She called this process ecotaxis because they were migrating to find their preferred ecological environment." The work was a crucial addition in understanding the mechanisms of the immune system. Between 1975 and 1984 de Sousa continued her studies of lymphocytes in the USA while she worked at New York\'s Memorial Sloan Kettering Cancer Center and elsewhere. Towards the end of her time there, she began to think more widely about science. "She became interested in the possibility that lymphocytes might be circulating not only to accomplish immune functions...but also to take part in other important physiological processes", says Veiga-Fernandes. One such process was the control of iron metabolism; since haemochromatosis was prevalent in northern Portugal, it was one of the factors that eventually drew de Sousa home. She also recognised that if biomedical science was to flourish in Portugal, it would need new structures. Her ambition was to ensure that talented young scientists could be identified, trained, and helped to travel to the best laboratories in other countries.

As Veiga-Fernandes comments, de Sousa used her acquired scientific prestige to good effect. "She became intimately involved in scientific policy making in Portugal. She started discussions at the highest level, with the ministry of science." Her arguments bore fruit. "She knew how to talk and convince politicians", says Freitas. The outcome was the creation of two PhD programmes. One was run by the Calouste Gulbenkian Foundation in Lisbon and the other, a Doctoral Programme in Areas of Basic and Applied Biology, generally known as GABBA, was led by de Sousa and started in 1996 at the University of Porto. These schemes were ground-breaking in Portugal and their effect on the country\'s biomedical science was, to use Veiga-Fernandes\'s description, "transformative".

"Maria was very determined", says Freitas, who got to know de Sousa at the University of Glasgow when they were both doing their PhDs. "She could be critical, but she always showed an interest in what you were doing, and encouraged you to go on." Costa describes her as generous and with a great sense of humour. "She played music. She wrote poetry," he says. "Every encounter with her had a lot of laughter." Like Costa, Veiga-Fernandes first met de Sousa as a GABBA student and recalls that "she was always very curious, and never automatically satisfied with the answers she was given". Veiga-Fernandes adds that "She was tremendously persistent, both from a scientific and a political point of view."
